The development of anticholinergics in the management of COPD

References

• BarnesPJ1986Neural control of human airways in health and diseaseAm Rev Respir Dis13412893143538958
   PubMed Web of Science ®Google Scholar
• BarnesPJ1993Muscarinic receptor subtypes in airwaysLife Sci52521488441331
   PubMed Web of Science ®Google Scholar
• BarnesPJ1999Managing chronic obstructive pulmonary diseaseLondonScience Press Ltd
   Google Scholar
• BarnesPJ2000The pharmacological properties of tiotropiumChest11763565
   Web of Science ®Google Scholar
• BarnesPJ2004AnticholinergicsCelliBRPharmacotherapy in chronic obstructive pulmonary diseaseNew YorkMarcel Dekker Inc
   Google Scholar
• BrewisRAL1990Classic papers in asthmaLondonScience Press Ltd
   Google Scholar
• [BTS] British Thoracic Society1997The British Thoracic Society Guidelines for the management of chronic obstructive pulmonary diseaseThorax52Suppl5S1S28
   Google Scholar
• CasaburiRKukafkaDCooperC2005Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPDChest1278091715764761
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPW2002A long term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J192172411866001
   PubMed Web of Science ®Google Scholar
• CelliBZuWallackRWangS2003Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumesChest1241748
   Web of Science ®Google Scholar
• CelliBR2004Pharmacotherapy in chronic obstructive pulmonary diseaseNew YorkMarcel Dekkr Inc
   Google Scholar
• ChapmanKRManninoDMSorianoJB2006Epidemiology and costs of chronic obstructive pulmonary diseaseEur Respir J2718820716387952
   PubMed Web of Science ®Google Scholar
• ChapmanKR1991Therapeutic algorithm for COPDAm J Med9117s73s1951400
   PubMed Web of Science ®Google Scholar
• ChapmanKR1993History of anticholinergic treatment in airways diseaseGrossNJLondonFranklin Scientific Publcations Ltd
   Google Scholar
• CoeCLBarnesPJ1986Reduction of nocturnal asthma: an inhaled anti-cholinergic drugChest9048583530643
   PubMed Web of Science ®Google Scholar
• CooperCBTashkinDP2005Recent developments in inhaled therapy in stable obstructive pulmonary diseaseBMJ330640415774995
   PubMed Web of Science ®Google Scholar
• CrockettA2000Managing chronic obstructive pulmonary disease in primary careLondonBlackwellSciences
   Google Scholar
• Di MarcoFVergaMSantusP2006Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot studyResp Med100192532
   PubMed Web of Science ®Google Scholar
• DisseBSpeckGARomingerKL1999Tiotropium (Spiriva): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sci64457810069510
   PubMed Web of Science ®Google Scholar
• DonahueJFVan NoordJABatemanED2002A 6 month placebo controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterolChest122475512114338
   PubMed Web of Science ®Google Scholar
• DusserDBravoMLIacono2006The effect of tiotropium on exacerbations and airflow in patietns with COPDEur Respir J275475516507855
   PubMed Web of Science ®Google Scholar
• GandeviaB1975Historical review of the use of parasympatholytic agents in the treatment of respiratory disordersPostgrad Med J5121328
   Web of Science ®Google Scholar
• GrossNBankwalaZ1987Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxaemic patietns with chronic obstructive pulmonary diseaseAm Rev Respir Dis136109143118746
   PubMed Web of Science ®Google Scholar
• GrossNJ1993Anticholinergic therapy in obstructive airways diseaseLondonFranklin Scientific Publications Ltd
   Google Scholar
• GrossNJ1995Airway inflammation in COPD: Reality or myth?Chest107S21013
   PubMed Web of Science ®Google Scholar
• HalpinDMG2001COPDLondonMosby Harcourt Publishers
   Google Scholar
• HardyJPRGogginPLGrahamP1992Bronchodilation effect of oxitropium bromide compared with ipratropium bromide [abstract]Thorax48865
   Google Scholar
• IkedaANishimuraKKoyamaH1995Comparative dose response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary diseaseThorax506267886652
   PubMed Web of Science ®Google Scholar
• KarpalJPPesinJGreenbergD1990A comparison of the effects of ipratropium bromide and metaproterenol sulphate in acute exacerbations of COPDChest9883592145136
   PubMed Web of Science ®Google Scholar
• KarpalJP1993The use of anticholinergic drugs in acute exacerbations of chronic obstructive pulmonary diseaseGrossERLondonFranklin Scientific Publications Ltd
   Google Scholar
• LittnerMRIlowitoJSTashkinDP2000Long acting bronchodilation with once daily dosing of Tiotropium (Spiriva) in stable chronic obstructive diseaseAm J Respir Crit Care Med161(pt1)11364210764302
   PubMed Web of Science ®Google Scholar
• [NCCCC] National Collaborating Centre for Chronic Conditions2004National guidelines on the management of chronic obstructive pulmonary disease in primary and secondary careThorax591232
   Google Scholar
• O’DonnellDEFlugeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J2004238324015218994
   PubMed Web of Science ®Google Scholar
• PauwelsRABuistASCalverleyPM2001Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summaryAm J Respir Crit Care Med16312567611316667
   PubMedGoogle Scholar
• PeelETAndersonGCheongB1984A compariosn of oxitropium bromide and ipratropium bromide in asthmaEur J Respir Dis6510686230249
   PubMedGoogle Scholar
• RebuckASChapmanKRAbboudR1987Nebulised anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency roomAm J Med8259642879458
   PubMed Web of Science ®Google Scholar
• ReesPJ2002Tiotropium in the management of chronic obstructive respiratoy diseaseEur Respir J19205611865999
   PubMed Web of Science ®Google Scholar
• RennardSSerbyCWGhafouriG1996Extended therapy with ipratropium is asociated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trilsChest11062708681667
   PubMed Web of Science ®Google Scholar
• SalpeterSRBuckleyNSSalpeterEE2006Meta-analysis:Anticholinergics, but not B-agonists, reduce severe exacerbations and respiratory mortality in COPDJ Gen Intern Med211917703327
   PubMed Web of Science ®Google Scholar
• SerbyCW2002Tiotropium: 1-year studies versus placebo/ipratropiumEur Respir Rev12402
   Google Scholar
• TuratoGZuinRBaroldoS2002Lung pathology in chronic obstructive pulmonary disease [online] Accessed on. URL: http://www.copdprofessional.org/literature/big_articles/suetta.html.2005
   Google Scholar
• VinckenWVan NoordJAGreefhorstAPM2006Improved health outcomes in patients with COPD during 1 year’s treatment with tiotropiumEur Respir J192091611871363
   PubMed Web of Science ®Google Scholar
• WedzichaJAIndPMilesA2001The effective management of chronic obstructive pulmonary diseaseLondonAesculapius Med Pr
   Google Scholar
• WiddicombeJG1966Action potentials in parasympathetic and sympathetic efferent fibres to the trachea and lungs of cats and dogsJ Physiol18656885914258
   PubMed Web of Science ®Google Scholar
• WitekTJMahlerDA2002Validity and patterns of response of dyspnea measures in a 6 month bronchodilator intervention trial in COPD [abstract]Am J Respir Crit Care Med165A266
   Google Scholar